Publications

List of Ludger papers - PubMed Link





Talks & Presentations


5th Annual Congress of AnalytiX 2017 - Fukuoka, Japan - March 22-24, 2017
Automated High-Throughput Permethylation for Glycosylation Analysis Using MALDI-TOF-MS
Archana Shubhakar





GlycoPar workshop - Liverpool, UK - September 12-15, 2016
Analysis of Erythropoietin Glycosylation
Dr Daniel Spencer





GlycoPar workshop - Liverpool, UK - September 12-15, 2016
Procainamide labelling: part of a sensitive workflow for the identification and quantitation of potential glycan drug targets by HILIC-HPLC-ESI-MS/MS
Dr Katherine Wongtrakul-Kish





GlycoPar workshop - Liverpool, UK - September 12-15, 2016
First steps in the development of a high throughput method for O-glycosylation analysis
Maximilianos Kotsias





37th BMSS Annual Meeting - Eastbourne, UK - September 13-15, 2016
Biopharmaceutical erythropoietin characterisation: critical quality attribute (CQA) mapping using LC-ESI-Qtof and automated database searching of glycopeptide and glycan analytes
Radoslaw Kozak





IgG meeting - Dubrovnik, Croatia - June 2016
30 Years of IgG Glycosylation and Disease: The Oxford-Tokyo RA Study
Dr Daryl Fernandes





Series of presentations to biopharmaceutical developers - China - April 2016
Drug Glycoprofiling: What the most successful biopharma companies do to satisfy the Regulators and outpace their competitors
Dr Daryl Fernandes





Metrology of Carbohydrates - Brussels, Belgium - 18th February 2016
Industry perspective for glycan needs
Dr Daniel Spencer





Glycobiotechnology 2016 - Manchester, UK - 4th & 5th April 2016
A profile of Ludger Ltd
Dr Daniel Spencer





Presentation to the China FDA(CFDA) - Shanghai, China - April 3, 2015
Assessing the regulatory significance of changes in biopharmaceutical glycosylation
Dr Daryl Fernandes





Series of presentations to biopharmaceutical developers - Wuhan, Zhuhai, Guangzhou and Shenyang, China - March 20-28, 2015
Demonstrating comparability of drug glycosylation, and what Glycosylation Critical Quality Attribute need to be taken into consideration for Drugs quality control
Dr Daryl Fernandes





11th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2014), CASSS - Napa, CA, USA - September 9-14, 2014
Reliability of a semi-automated, High Throughput (HT) MS based glycomics system for discovery of glycan biomarkers and Quality by Design (QbD) studies of glycoprotein therapeutics
Archana Shubhakar





10th European Symposium on Saliva - Egmond aan Zee, The Netherlands - May 14-17, 2014
Saliva glycosylation analysis
Radoslaw P. Kozak





GlycoComparability of Biosimilars Workshop - Shanghai, China - April 8, 2014
Assessing the regulatory significance of changes in biopharmaceutical glycosylation with reliable glycometrics
Dr Daryl Fernandes





Waters Biopharmaceutical Analysis Symposium - Elstree, UK- March 27, 2014
Selecting the Most Appropriate Analytical Methods for Glycosylation Analysis of Specific Glycoproteins
Dr Louise Royle





Presentation to the FDA - Bethesda, Maryland USA - January 31, 2014
Assessing the regulatory significance of changes in biopharmaceutical glycosylation with reliable glycometrics
Dr Daryl Fernandes





World Biopharm Forum 2013, Continuous Processing in Biopharmaceutical Manufacturing - Cambridge, UK - July 1, 2013
Correction of out-of-specification drug glycosylation during continuous processing
Dr Louise Royle





XXII International Symposium on Glycoconjugates - Dalian, China - June 25, 2013
Improved O-glycan Analysis Methods
Radoslaw P. Kozak





International GlycomicsSymposium - San Sebastien, Spain - July 19-21, 2012
Ludger - A Glycoprofiling Bridge Between Academia and Biopharma
Dr Daniel Spencer